Association of the programmed death ligand‐1 combined positive score in tumors and clinicopathological features in esophageal cancer

BACKGROUND: The combined positive score (CPS) of the programmed death ligand‐1 (PD‐L1) 22C3 assay is a predictive marker of pembrolizumab monotherapy for advanced esophageal cancer (EC) patients. However, little is known about the association of the PD‐L1 22C3 CPS with the clinicopathological featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ziling, Jin, Yan, Cai, Xu, Chen, Lijun, Shen, Xuxia, Li, Bin, Chen, Haiquan, Li, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841709/
https://www.ncbi.nlm.nih.gov/pubmed/34953041
http://dx.doi.org/10.1111/1759-7714.14285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841709/
https://www.ncbi.nlm.nih.gov/pubmed/34953041
http://dx.doi.org/10.1111/1759-7714.14285

Ejemplares similares